发明公开
- 专利标题： DOSING REGIMENS FOR THE TREATMENT OF FABRY DISEASE
- 专利标题（中）： 剂量计划治疗克罗恩FABRY
-
申请号： EP12758017.3申请日： 2012-03-08
-
公开(公告)号： EP2683382A2公开(公告)日： 2014-01-15
- 发明人: GREENE, Douglas, Stuart , VALENZANO, Kenneth, Joseph
- 申请人： Amicus Therapeutics, Inc.
- 申请人地址： 1 Cedar Brook Drive Cranbury, NJ 08512 US
- 专利权人： Amicus Therapeutics, Inc.
- 当前专利权人： Amicus Therapeutics, Inc.
- 当前专利权人地址： 1 Cedar Brook Drive Cranbury, NJ 08512 US
- 代理机构： Miller Sturt Kenyon
- 优先权： US201161451798P 20110311; US201161578201P 20111220; US201261596165P 20120207
- 国际公布： WO2012125402 20120920
- 主分类号： A61K31/445
- IPC分类号： A61K31/445
摘要：
The presently disclosed subject matter provides a dosing regimen and administration schedule for the use of 1-deoxygalactonojirimycin and enzyme replacement therapy for the treatment of Fabry disease. The presently disclosed subject matter further provides a dosing regimen and administration schedule for the use of migalastat hydrochloride and agalsidase for the treatment of Fabry disease.
公开/授权文献
- EP2683382B1 DOSING REGIMENS FOR THE TREATMENT OF FABRY DISEASE 公开/授权日：2020-04-22
信息查询
IPC分类:
